Pfizer Inc., US7170811035

Pfizer Inc. stock lists analyst webcast November 3, 2026, slightly lower pre-market

Published on 10/26/2026 at 08:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pfizer develops medicines and vaccines across several therapeutic areas. At Lang & Schwarz the stock trades pre-market at EUR 26.82 on October 26, 2026, 0.26 percent below the Xetra close of October 23, 2026.

Upcoming company webcast

  • Pfizer's website lists an analyst webcast for November 3, 2026.
  • The home market is the S&P 500 in the United States.
  • Pfizer Inc. stock trades pre-market at EUR 26.82 at 8:21 a.m. CET at Lang & Schwarz on October 26, 2026, 0.26 percent below the Xetra close of October 23, 2026.
Pfizer Inc., US7170811035, Illustration mit AI erstellt.

Pfizer Inc. lists a November 3, 2026 webcast of a conference call with analysts on its website. The listing identifies the event as an analyst webcast.

Agenda for Pfizer

The company’s website lists the November 3, 2026 event as a webcast of a conference call with analysts. The date falls within the next ten Xetra trading days and is the next company-specific item identified for the stock in the company material.

Ahead of the Xetra open

The indicated move is EUR 0.07 below the Xetra reference. The continuously updated real-time quote of Pfizer Inc. stock shows the further course from the Xetra open at 9:00 a.m. CET/CEST.

Pfizer's business and the day

Pfizer develops medicines and vaccines across areas including internal medicine, inflammation and immunology, vaccines and oncology, according to its website. The site identifies these areas as part of Pfizer’s research and development focus. The home market is the United States, represented here by the S&P 500. Market context: Market report S&P 500.

More news and analysis on Pfizer Inc. stock

Disclaimer...
en | US7170811035 | PFIZER INC. | boerse | 70412755 |